SARAH GUTIERREZ: Open Payments
NPI 1528495173 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,197 in 120 payments from 17 companies in 2025. Trend: 2023 $1,207 · 2024 $1,918 · 2025 $2,197
Food & beverage: $2,103Education: $95
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 28 | $447 |
| ABBVIE INC. | 26 | $437 |
| UCB, Inc. | 10 | $237 |
| Lilly USA, LLC | 13 | $190 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $176 |
| Amgen Inc. | 8 | $163 |
| Novartis Pharmaceuticals Corporation | 6 | $137 |
| Regeneron Healthcare Solutions, Inc. | 3 | $85 |
| GENZYME CORPORATION | 3 | $80 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 4 | $73 |
Products named: TREMFYA, RINVOQ, Bimzelx, TALTZ, SKYRIZI, DUPIXENT, OTEZLA, COSENTYX.
Industry payments across NV — which companies pay providers there.
